Kriya acquires gene therapy startup for undisclosed sum; Compugen wins milestone payment from AstraZeneca
Shankar Ramaswamy’s Kriya Therapeutics secured a buyout for an unknown amount Wednesday morning.
Kriya acquired privately held Redpin Therapeutics, which is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
